Established in 1999, the World Anti-Doping Agency (WADA) is an international, independent agency composed and funded equally by the Sport Movement and Governments of the world. Our key activities include scientific research, education, development of anti-doping capacity, investigations, and monitoring compliance with the World Anti-Doping Code (Code) — the document harmonizing anti-doping policies across all sports and all countries. WADA’s mission is to lead a collaborative worldwide movement for doping-free sport.
Science is key to driving advances in anti-doping. Innovative, fact-based research helps the anti-doping community identify new trends in doping, new drugs, new delivery mechanisms and new methods of detection.
WADA’s Health, Medical and Research Committee (HMRC), which is one of the Agency’s Standing Committees, monitors scientific developments in sport with the aim of safeguarding doping-free sport practice. With this aim, it oversees the following WADA Expert Groups: Prohibited List, Therapeutic Use Exemptions (TUE), Laboratory accreditation and Gene Doping. The HRMC Committee is also involved in the selection of WADA-funded Scientific Research Grant Projects.
Since 2001, WADA has committed more than US$73 million to helping researchers around the world develop breakthroughs in anti-doping science. The Agency’s scientific research grants are critical because they increase the volume of research dedicated to developing new and improved detection methods for performance-enhancing substances and methods as well as attract the best minds to this cause.
WADA-funded Scientific Research Grant Projects.
On a yearly basis, WADA promotes and funds Scientific Research Grant Projects regarding development, or optimization, of analytical tools for the detection and/or quantification of doping substances or methods, consolidation of the Athlete Biological Passport (ABP); as well as, the pharmacology of prohibited substances and drug cocktails. With this objective, WADA gives high priority to projects with direct and imminent applicability in the fight against doping in sport; and therefore, rarely funds basic research projects.
For more information, please visit: https://www.wada-ama.org/en/research and https://www.wada-ama.org/sites/default/files/2018_researchtopics_en.pdf
- Basic Science
- Clinical Science
- Drug Development
- Faculty
- Junior Faculty